Lipid Peroxidation Products, and Vitamin and Trace Element Status in Patients with Cancer Before and After Chemotherapy, Including Adriamycin. A Preliminary Study

Overview

Journal Biol Trace Elem Res

Date 1995 Jan 1

PMID 7779537

Citations 18

Authors

M Faber

C Coudray

H Hida

M Mousseau

A Favier

Affiliations

Soon will be listed here.

Abstract

Adriamycin is a potent chemotherapeutic agent used in the treatment of human neoplastic diseases. A major side effect limiting the use of this drug is its toxic effect on the heart. Several hypotheses have been proposed to explain the cardiotoxicity of Adriamycin. However, the most plausible hypothesis seems to be the reduction of Adriamycin and free radical production, which induces lipid peroxidation and oxidative damages in the heart. We have thus undertaken this preliminary study to investigate Adriamycin-induced lipid peroxidation by the measurement of plasma thiobarbituric acid reactant materials and antioxidant systems, namely glutathione content, glutathione peroxidase activity, and vitamin and trace element status, in patients with cancer before and after chemotherapy, including Adriamycin. The concentration of thiobarbituric acid reactant materials in plasma of patients with cancer was higher than in controls and was further increased after chemotherapy. Blood glutathione and plasma glutathione peroxidase activity, as well as plasma zinc and selenium in patients with cancer, were decreased, but not further modified by chemotherapy. However, only zinc and selenium levels reached a significant level. In contrast, plasma vitamin E and beta-carotene levels were not significantly increased in patients with cancer. Finally, plasma vitamin A and copper levels were not modified either in patients with cancer or by chemotherapy.

Citing Articles

Advancements in nanotechnology-driven photodynamic and photothermal therapies: mechanistic insights and synergistic approaches for cancer treatment.

Shabnum S, Siranjeevi R, Raj C, Saravanan A, Vickram A, Chopra H RSC Adv. 2024; 14(52):38952-38995.

PMID: 39659608 PMC: 11629304. DOI: 10.1039/d4ra07114j.

Chemotherapy on hematological and biochemical parameters in breast cancer patients.

Pullakanam T, Mannangatti M, Ramesh A, Nekkala R, Vijayalakshmi P Caspian J Intern Med. 2024; 16(1):132-140.

PMID: 39619746 PMC: 11607108. DOI: 10.22088/cjim.16.1.132.

Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in mice.

Singh A, Ruiz D, Rasheed M, Avery T, Turner D, Abell A bioRxiv. 2024; .

PMID: 38915544 PMC: 11195070. DOI: 10.1101/2024.06.10.598291.

Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients.

Saleh S, Adly H, Abdelkhaliq A, Nassir A Curr Urol. 2020; 14(1):44-49.

PMID: 32398996 PMC: 7206590. DOI: 10.1159/000499261.

Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.

Sahin I, Bilir B, Ali S, Sahin K, Kucuk O Integr Cancer Ther. 2019; 18:1534735419835310.

PMID: 30897972 PMC: 6431760. DOI: 10.1177/1534735419835310.

References

Heath R, Tappel A . A new sensitive assay for the measurement of hydroperoxides. Anal Biochem. 1976; 76(l):184-91. DOI: 10.1016/0003-2697(76)90277-3. View

Coudray C, Mouhieddine S, Richard M, Arnaud J, de Leiris J, Favier A . Effects of adriamycin on chronic cardiotoxicity in selenium-deficient rats. Basic Res Cardiol. 1992; 87(2):173-83. DOI: 10.1007/BF00801964. View

Ozols R, Young R, Speyer J, Sugarbaker P, Greene R, Jenkins J . Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res. 1982; 42(10):4265-9. View

Young R, Ozols R, Myers C . The anthracycline antineoplastic drugs. N Engl J Med. 1981; 305(3):139-53. DOI: 10.1056/NEJM198107163050305. View

Richard M, Portal B, Meo J, Coudray C, Hadjian A, Favier A . Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem. 1992; 38(5):704-9. View

Neidle S . The molecular basis for the action of some DNA-binding drugs. Prog Med Chem. 1979; 16:151-221. DOI: 10.1016/s0079-6468(08)70188-7. View

Schisselbauer J, Crescimanno M, DAlessandro N, CLAPPER M, Toulmond S, Tapiero H . Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype. Cancer Commun. 1989; 1(2):133-9. DOI: 10.3727/095535489820875291. View

Gunzler W, Kremers H, Flohe L . An improved coupled test procedure for glutathione peroxidase (EC 1-11-1-9-) in blood. Z Klin Chem Klin Biochem. 1974; 12(10):444-8. DOI: 10.1515/cclm.1974.12.10.444. View

Powis G . Free radical formation by antitumor quinones. Free Radic Biol Med. 1989; 6(1):63-101. DOI: 10.1016/0891-5849(89)90162-7. View

10.

Canada R, Saway W, Thompson E . Interactions of adriamycin with a calcium binding site. Biochem Biophys Res Commun. 1988; 151(2):679-85. DOI: 10.1016/s0006-291x(88)80334-6. View

11.

Rajagopalan S, Politi P, Sinha B, Myers C . Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res. 1988; 48(17):4766-9. View

12.

Winterbourn C, Vile G, Monteiro H . Ferritin, lipid peroxidation and redox-cycling xenobiotics. Free Radic Res Commun. 1991; 12-13 Pt 1:107-14. DOI: 10.3109/10715769109145774. View

13.

Davies K, Doroshow J . Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem. 1986; 261(7):3060-7. View

14.

Montali U, Del Tacca M, Bernardini C, Segnini D, Solaini G . Cardiotoxic effects of adriamycin and mitochondrial oxidation in rat cardiac tissue. Drugs Exp Clin Res. 1985; 11(3):219-22. View

15.

Nohl H . Identification of the site of adriamycin-activation in the heart cell. Biochem Pharmacol. 1988; 37(13):2633-7. DOI: 10.1016/0006-2952(88)90257-2. View

16.

Lefrak E, Pitha J, ROSENHEIM S, Gottlieb J . A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973; 32(2):302-14. DOI: 10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2. View

17.

Takahashi K, Mayumi T, Kishi T . Evidence that lipid peroxidation by doxorubicin does not initiate the beat inhibition of cultured mouse myocardial cells. Chem Pharm Bull (Tokyo). 1987; 35(11):4626-31. DOI: 10.1248/cpb.35.4626. View

18.

Arnaud J, Bellanger J, Bienvenu F, Chappuis P, Favier A . Recommended method for assaying serum zinc with flame atomic absorption. Ann Biol Clin (Paris). 1986; 44(1):77-87. View

19.

Akerboom T, Sies H . Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981; 77:373-82. DOI: 10.1016/s0076-6879(81)77050-2. View

20.

Olson R, BOERTH R, Gerber J, Nies A . Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci. 1981; 29(14):1393-401. DOI: 10.1016/0024-3205(81)90001-1. View